These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 134897)

  • 1. Long-term treatment with beta-blockers after myocardial infarction.
    Ahlmark G; Saetre H
    Eur J Clin Pharmacol; 1976 Jun; 10(2):77-83. PubMed ID: 134897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris.
    Heterington DJ; Comerford MB; Nyberg G; Besterman EM
    Br Heart J; 1973 Mar; 35(3):320-33. PubMed ID: 4632566
    [No Abstract]   [Full Text] [Related]  

  • 3. Short-term and long-term tolerance to beta-blockade with alprenolol in patients admitted for a suspected acute myocardial infarction.
    Rasmussen SL; Pedersen F
    Acta Med Scand Suppl; 1984; 680():40-9. PubMed ID: 6375280
    [No Abstract]   [Full Text] [Related]  

  • 4. Angina pectoris, hypertension, decompensation and return to work during two years' follow-up.
    Vedin A; Wilhelmson C
    Acta Med Scand Suppl; 1975; 575():25-30. PubMed ID: 1098399
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of alprenolol on mortality among patients with definite or suspected acute myocardial infarction. Preliminary results.
    Andersen MP; Bechsgaard P; Frederiksen J; Hansen DA; Jürgensen HJ; Nielsen B; Pedersen F; Pedersen-Bjergaard O; Rasmussen SL
    Lancet; 1979 Oct; 2(8148):865-8. PubMed ID: 90964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QT time in patients treated with alprenolol or placebo after myocardial infarction.
    Nyberg G; Vedin A; Wilhelmsson C
    Br Heart J; 1979 Apr; 41(4):452-5. PubMed ID: 380606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison between alprenolol in tablet form (Aptin) and in "sustained release" form (Aptin Durules) in angina pectoris].
    Lorentzen F; Jorgensen P; Nielsen E; Nyberg G; Hvidt S
    Ugeskr Laeger; 1973 Jul; 135(27):1431-8. PubMed ID: 4585750
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results.
    Wilhelmsson C; Vedin JA; Wilhelmsen L; Tibblin G; Werkö L
    Lancet; 1974 Nov; 2(7890):1157-60. PubMed ID: 4139587
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic alprenolol treatment of patients with acute myocardial infarction after discharge from hospital.
    Vedin A; Wilhelmsson C; Werkö L
    Acta Med Scand Suppl; 1975; 575():3-56. PubMed ID: 808105
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reduction of sudden death after myocardial infarct with chronic alprenolol treatment].
    Tibblin G; Vedin A; Wilhelmsen L; Werkö L; Wilhelmsson C
    Lakartidningen; 1975 Jun; 72(25):2683-6. PubMed ID: 1095869
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Salvage of ischaemic myocardium by alprenolol.
    Jürgensen HJ; Frederiksen J; Hansen DA; Pedersen-Bjergaard O
    Acta Med Scand Suppl; 1984; 680():27-33. PubMed ID: 6375277
    [No Abstract]   [Full Text] [Related]  

  • 12. Limitation of myocardial infarct size in patients less than 66 years treated with alprenolol.
    Jürgensen JH; Frederiksen J; Hansen DA; Pedersen-Bjergaard O
    Br Heart J; 1981 May; 45(5):583-8. PubMed ID: 7016150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of alprenolol in combination with hydralazine in essential hypertension. A double-blind, crossover study and a long-term follow-up study.
    Pape J
    Acta Med Scand Suppl; 1974; 554():55-62. PubMed ID: 4593674
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of single doses of alprenolol and two cardioselective beta-blockers (H 87-07 and H 93-26) on exercise-induced angina pectoris.
    Adolfsson L; Areskog NH; Furberg C; Johnsson G
    Eur J Clin Pharmacol; 1974; 7(2):111-8. PubMed ID: 4152864
    [No Abstract]   [Full Text] [Related]  

  • 15. Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
    Bjerle P; Jacobsson KA
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):101-16. PubMed ID: 4218804
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of a beta-adrenergic receptor blocker in myocardial infarction treated for one year from onset.
    Reynolds JL; Whitlock RM
    Br Heart J; 1972 Mar; 34(3):252-9. PubMed ID: 4111391
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preventive effects of beta-blockers on myocardial infarction and on cardiac accidents following a first infarct].
    Fanchamps A
    Nouv Presse Med; 1978 Sep; 7(31):2741-5. PubMed ID: 30954
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of aptine, a new adrenergic beta blockader, in angina pectoris].
    Leduc G; Guiha N
    Union Med Can; 1971 May; 100(5):969-72. PubMed ID: 4147301
    [No Abstract]   [Full Text] [Related]  

  • 19. The long-term effect of alprenolol on plasma apolipoproteins A-I and B.
    Gerdes LU; Jürgensen HJ; Groot PH; Faergeman O
    Acta Med Scand; 1988; 223(5):419-22. PubMed ID: 3132028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of alprenolol in the secondary prevention of myocardial infarction.
    Jürgensen HJ
    Acta Med Scand Suppl; 1984; 680():59-64. PubMed ID: 6375282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.